Show simple item record

dc.contributor.authorNutting, C
dc.contributor.authorMorden, J
dc.contributor.authorBeasley, M
dc.contributor.authorBhide, S
dc.contributor.authorEmson, M
dc.contributor.authorEvans, M
dc.contributor.authorFresco, L
dc.contributor.authorGujral, D
dc.contributor.authorHarrington, K
dc.contributor.authorLemon, C
dc.contributor.authorNeupane, R
dc.contributor.authorNewbold, K
dc.contributor.authorPrestwich, R
dc.contributor.authorRobinson, M
dc.contributor.authorSanghera, P
dc.contributor.authorSivaramalingam, M
dc.contributor.authorSydenham, M
dc.contributor.authorWells, E
dc.contributor.authorWitts, S
dc.contributor.authorHall, E
dc.coverage.spatialBarcelona, SPAIN
dc.date.accessioned2018-07-04T13:09:42Z
dc.date.issued2017-03-01
dc.identifierhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000433310700090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9
dc.identifier.citationRADIOTHERAPY AND ONCOLOGY, 2017, 122 pp. 44 - 45 (2)
dc.identifier.issn0167-8140
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1979
dc.identifier.eissn1879-0887
dc.identifier.doi10.1016/S0167-8140(17)30227-X
dc.format.extent44 - 45 (2)
dc.languageeng
dc.language.isoeng
dc.publisherELSEVIER IRELAND LTD
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectOncology
dc.subjectRadiology, Nuclear Medicine & Medical Imaging
dc.titleCOSTAR trial results: 3-D Conformal Radiotherapy vs Cochlea-Sparing IMRT in parotid cancer patients
dc.typeOther
rioxxterms.versionofrecord10.1016/S0167-8140(17)30227-X
rioxxterms.licenseref.startdate2017-03-01
rioxxterms.typeOther
dc.relation.isPartOfRADIOTHERAPY AND ONCOLOGY
pubs.finish-date2017-03-18
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/ICR-CTSU Urology and Head and Neck Trials Team
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/ICR-CTSU Urology and Head and Neck Trials Team
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.publication-statusPublished
pubs.start-date2017-03-16
pubs.volume122
pubs.embargo.termsNot known
icr.researchteamClinical Trials & Statistics Uniten_US
icr.researchteamICR-CTSU Urology and Head and Neck Trials Teamen_US
icr.researchteamTargeted Therapyen_US
dc.contributor.icrauthorMorden, James Peter
dc.contributor.icrauthorEmson, Marie
dc.contributor.icrauthorSydenham, Mark
dc.contributor.icrauthorHall, Emma
dc.contributor.icrauthorHarrington, Kevin


Files in this item

Thumbnail
Thumbnail

This item appears in the following collection(s)

Show simple item record